The Absence of Obstructive Sleep Apnea May Protect against Non-Alcoholic Fatty Liver in Patients Undergoing Bariatric Surgery

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Corey, Kathleen E ^a,b   Misdraji, Joseph ^a   Zheng, Hui ^a,b   Malecki, Kyle M ^a   Kneeman, Jacob ^a   Gelrud, Louis ^c   Chung, Raymond T ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Bon Secours Richmond Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BARIATRIC SURGERY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER PROTECTION; MAJOR CLINICAL STUDY; MALE; NEGRO; NONALCOHOLIC FATTY LIVER; OBESITY; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; SLEEP DISORDERED BREATHING; BIOPSY; BLACK PERSON; BLOOD; CAUCASIAN; ETHNOLOGY; FATTY LIVER; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALANINE TRANSAMINASE; BARIATRIC SURGERY; BIOPSY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY LIVER; FEMALE; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84877041974     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062504     Document Type: Article

References (13)

1. Greenfield V, Cheung O, Sanyal AJ, (2008) Recent advances in nonalcholic fatty liver disease. Curr Opin Gastroenterol 24: 320-327.
2. Dunn W, Xu R, Wingard DL, Rogers C, Angulo P, et al. (2008) Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 103: 2263-2271.
3. Targher G, Marra F, Marchesini G, (2008) Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 51: 1947-1953.
4. Charlton M, (2008) Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain? Hepatology 47: 1431-1433.
5. Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, et al. (2004) Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 19: 854-858.
6. Gholam PM, Flancbaum L, Machan JT, Charney DA, Kotler DP, (2007) Nonalcoholic fatty liver disease in severely obese subjects. Am J Gastroenterol 102: 399-408.
7. Machado M, Marques-Vidal P, Cortez-Pinto H, (2006) Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol 45: 600-606.
8. Corey KE, Lai M, Gelrud L, Misdraji J, Barlow LL, et al. (2012) Non-High Density Lipoprotein Cholesterol as a Biomarker for Non-Alcoholic Steatohepatitis. Clin Gastroenterol Hepatol.
9. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321.
10. Norman D, Bardwell WA, Arosemena F, Nelesen R, Mills PJ, et al. (2008) Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea. Sleep 31: 121-126.
11. Aron-Wisnewsky J, Minville C, Tordjman J, Levy P, Bouillot JL, et al. (2012) Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J Hepatol 56: 225-233.
12. Piguet AC, Stroka D, Zimmermann A, Dufour JF, (2010) Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN. Clin Sci (Lond) 118: 401-410.
13. Savransky V, Bevans S, Nanayakkara A, Li J, Smith PL, et al. (2007) Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol 293: G871-877.